Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

Gönczi Lóránt and Kürti Zsuzsanna and Rutka Mariann and Végh Zsuzsanna and Farkas Klaudia and Lovász Barbara Dorottya and Golovics Petra Anna and Gecse Krisztina Barbara and Szalay Balázs and Molnár Tamás and Lakatos Péter László: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.
BMC GASTROENTEROLOGY, 17 (1). Azonosító: 97.-Terjedelem: 7 p.. ISSN 1471-230X (2017)

[thumbnail of 3253720_Gonczi_BMC_u.pdf]
Preview
Text
3253720_Gonczi_BMC_u.pdf - Published Version

Download (515kB) | Preview
Creators:
Gönczi Lóránt MTMT
Kürti Zsuzsanna MTMT
Rutka Mariann MTMT
Végh Zsuzsanna MTMT
Farkas Klaudia MTMT
Lovász Barbara Dorottya MTMT
Golovics Petra Anna MTMT
Gecse Krisztina Barbara MTMT
Szalay Balázs MTMT
Molnár Tamás MTMT
Lakatos Péter László MTMT
Item Type: Journal Article
Journal or Publication Title: BMC GASTROENTEROLOGY
Date: 2017
Volume: 17
Number: 1
Page Range: Azonosító: 97.-Terjedelem: 7 p.
ISSN: 1471-230X
Publisher: Biomed Central Ltd.
Faculty/Unit: Faculty of Medicine
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 3253720
DOI azonosító: https://doi.org/10.1186/s12876-017-0654-1
Date Deposited: 2018. Jan. 31. 09:02
Last Modified: 2020. Feb. 14. 11:39
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12810
Web of Science® Times Cited: 16 View citing articles in Web of Science®

Actions (login required)

View Item View Item